INKT · MiNK Therapeutics, Inc.
$11.27
+0.27 (+2.45%)
At close · Aug 14
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Because the completion of anticipated funding is not entirely within the Company's control, the Company is required to disclose that substantial doubt exists about its ability to continue as a going concern for a period of one year after the date of filing of this Quarterly Report on Form 10-Q.”View the 10-Q filed Aug 13, 2026
Market Cap
$57.51M
Shares
5.10M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-08-13 | MiNK Therapeutics Second Quarter 2026 Financial Results | Event |
| 2026-08-13 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-06-17 | MiNK Therapeutics Annual Shareholders Meeting | Shareholder meeting |
| 2026-05-15 | MiNK Therapeutics First Quarter 2026 Financial Results | Event |
| 2026-05-15 | Earnings conference call (announced in 8-K) | Earnings call |
| 2026-03-31 | MiNK Therapeutics Fourth Quarter and Year End 2025 Financial Results | Event |
Key facts
CIK
1840229
CUSIP
603693201
13F (30d)
28 filings
28 filers
Visit website
Investor relations